Updated Jul 16, 2026
Galson Steven K has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Based on the SEC filing context provided, Steven K. Galson (listed as Galson Steven K) is a Director of Biocryst Pharmaceuticals Inc as of the filing date 2026-06-15. No additional professional background, education, or career history is included in the context you supplied. The entry confirms board governance involvement with Biocryst but does not provide further biographical details.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 15.3K | $0.00 |
Based on the SEC filing context provided, Steven K. Galson (listed as Galson Steven K) is a Director of Biocryst Pharmaceuticals Inc as of the filing date 2026-06-15. No additional professional background, education, or career history is included in the context you supplied. The entry confirms board governance involvement with Biocryst but does not provide further biographical …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Galson Steven K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.